Search Results 3751-3760 of 25449 for oral

1. Head and neck cancers - Doctors and departments - Mayo Clinic

   Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

2. The History of Otorhinolaryngology at Mayo Clinic

   Oral and Plastic Surgery and the Section of. Otolaryngology and Rhinology ... separate section of Laryngology, Oral and Plas- tic Surgery (Thomas J ...

3. Myelofibrosis Clinical Trials - Mayo Clinic Research

   Following the lead-in, a phase 2, randomized, double blind, 2 arm study of oral single agent PF 04449913 versus placebo will be tested in patients resistant ...

4. Congenital Heart Disease In Adults Clinical Trials - Mayo Clinic Research

   ... oral anticoagulation therapy vs. placebo for a 6 week period. Exercise during Heart Cath in CHD Patients Rochester, MN. The purpose of this study is to ...

5. Assess Glycemic Improvements in People with Type 2 Diabetes Using a Novel Hybrid Closed Loop Insulin Pump - Mayo Clinic

   ... (oral, intravaginal, transdermal). Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable,implantable). Placement ...

6. A Phase 2a/b Study of the Efficacy and Safety of Subcutaneous Amlitelimab in Adults With Nonresponsive Celiac Disease - Mayo Clinic

   * Any ongoing treatment with systemic immunosuppressants, systemic corticosteroids, or use of oral budesonide in the 12 weeks before screening. * Ongoing ...

7. A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

   Have active oral or genital herpes or are currently receiving treatment for HSV infection. 3. Have known sensitivity or allergy to systemic corticosteroids ...

8. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

   Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is ...

9. Olaparib and Atezolizumab Either Alone or in Combination in Treating Patients With Stage III-IV Triple Negative Breast Cancer - Mayo Clinic

   ... oral calcineurin inhibitors; high potency or oral steroids) 3.2.10 History of idiopathic pulmonary fibrosis, pneumonitis (including drug induced) ...

10. Phase II Venetoclax, Obinutuzumab and Bendamustine in High Tumor Burden Follicular Lymphoma as Front Line Therapy - Mayo Clinic

    Venetoclax is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is ...